INTRODUCTION
============

In January 2018, approximately 7.4 million Koreans (14.3% of the total population) were ≥65 years of age.[@b1-agmr-22-121] Korea has just entered the aged society phase and the growth rate of this aging population is among the most rapid worldwide. The proportions of older adults ≥65 years of age are expected to be 20% in 2026, 30% in 2034, and over 40% in 2058.[@b2-agmr-22-121]

Older patients generally use more drugs than younger people. Changes in pharmacokinetics and pharmacodynamics, poor homeostatic reserves, and increased frailty significantly increase the risk of adverse drug events (ADEs) in older populations.[@b3-agmr-22-121] Although statistical data about ADEs in older Koreans are limited, the United Kingdom and the United States studies showed that ADEs are a common cause of morbidity and mortality in older patients. In two UK hospitals, ADEs accounted for 6.5% of hospital admissions and patients admitted with ADEs were significantly older than patients without ADEs.[@b4-agmr-22-121] A US study also reported that ADEs are responsible for about 100,000 hospitalizations per year in adults ≥65 years of age and nearly half of these hospitalizations were among adults ≥80 years.[@b5-agmr-22-121] In addition, the prediction and detection of ADEs is challenging in older adults and far more difficult in patients with cognitive impairment.[@b6-agmr-22-121] Therefore the impact of ADEs could be underestimated in older populations. Furthermore, fragmented medical services in the Korean health system[@b7-agmr-22-121] suggest that ADEs among older Koreans may be an even more serious problem compared to other countries.

Medications whose risk of ADEs outweighs their expected clinical benefit when they are administered to older persons are considered potentially inappropriate medications (PIMs), especially when there are better-tolerated alternatives.[@b8-agmr-22-121] However, there is no widely-used, reliable PIMs list in Korea. Explicit criteria for screening PIMs that have been developed in other countries, such as the Beers criteria, are difficult to apply in Korean older people because of the differences in drug availability and prescribing behavior. The domestic PIMs list that Kim et al.[@b9-agmr-22-121] proposed in 2010 has not been used widely because the list was developed without the collaboration of geriatric academic societies and has not been disseminated effectively to doctors who prescribe medication to older people. The objective of this study was to develop a concise PIMs list to which Korean doctors who treat older people can easily refer in their daily practice.

MATERIALS AND METHODS
=====================

A research steering team was formed to recruit experts and prepare and circulate the content of the Delphi rounds. The team comprised 2 geriatricians, a family physician, a Delphi method expert, and a public health researcher. The final PIMs list was produced through 4 rounds of comprehensive structured expert surveys distributed through email (modified Delphi method).

Expert Panel Recruitment
------------------------

To generate an expert panel, we invited nomination of experts in geriatric medication from the Korean Geriatric Society, the Korean Academy of Clinical Geriatrics, the Korean Academy of Family Medicine, the Korean Association for Geriatric Psychiatry and the Korean Association of Geriatric Hospitals. All nominees were provided information regarding the study objectives and design and the commitment required for participation. Finally, the expert panel consisted of 14 geriatric specialists, including 10 geriatricians (7 family medicine doctors and 3 internal medicine doctors), 3 geriatric psychiatrists, and 1 clinical pharmacist.

First-Round Survey
------------------

The questionnaire for the first-round survey consisted of open-ended questions about the recommendations of preexisting PIMs screening tools published in English or Korean that the new Korean PIMs list should refer to, the appropriate number of items on the new list, and general opinions and comments regarding the research process.

Establishment of a Preliminary List and Second-Round Survey
-----------------------------------------------------------

According to the response of the first-round survey and literature review, a preliminary list was produced based on the 2015 Beers criteria,[@b10-agmr-22-121] the screening tool of older person's prescription (STOPP),[@b11-agmr-22-121] the PRISCUS (Latin for "old and venerable") list,[@b12-agmr-22-121] the PIMs list for the Korean elderly by Kim et al.,[@b9-agmr-22-121] the PIMs list from the Korean Health Insurance Review & Assessment Service,[@b13-agmr-22-121] and the PIMs list of the Seoul National University Bundang Hospital (not published in a peer-reviewed journal). Some screening tools published before 2010 were excluded because they included duplicated or out-of-date items. The research steering team reviewed the above screening tools and matched each item with the reimbursable drugs in Korea using the KIMs online medication database. Drugs that are not available in Korea were excluded from the preliminary list. The preliminary list included 98 medications that should be avoided by most older adults and 108 medications to be avoided by older adults with 24 specific conditions.

In the questionnaire for the second-round survey, the research steering team provided summarized information from the responses to the first round and the process of developing the preliminary list. The expert panel was asked to score with 5-point Likert scales the frequency (1, very rare; 2, rare; 3, average; 4, common; 5, very common) and severity (1, trivial; 2, mild; 3, average; 4, severe; 5, very severe) of the ADEs that are potentially caused by each item in the preliminary list. The panelists were allowed a "cannot judge" option and asked to state the reason why each item was inappropriate, preferred therapeutic alternatives, methods to minimize the risk, and other general comments. To help the expert panel evaluate the items, the reference and major rationale of each item and representative brand names of the drugs were included in the questionnaire.

Establishment of the First Draft of a Korean PIMs List and Third-Round Survey
-----------------------------------------------------------------------------

The clinical significance score (CSS) of the medications was defined as the product of the frequency and severity scores. According to the expert panel's suggestion that the appropriate number of PIMs items would be \<90, items with a CSS \<9 were excluded from the first draft of the Korean PIMs list. The draft included 49 medications that should be avoided by most older adults, regardless of co-morbid conditions, and 45 medications to be avoided by older adults with specific conditions. Based on the experts' opinions and literature review, the research steering team described the rationale and comments for each medicine on the PIMs list, including preferred therapeutic alternatives and exceptional situations. In the third-round survey, the expert panel was asked to state whether they agreed with the inclusion or exclusion of each item and if not, to present their rationale and supporting evidence.

Establishment of the Second Draft of the Korean PIMs List and Fourth-Round Survey
---------------------------------------------------------------------------------

Reflecting the experts' opinions in the third-round survey, the second draft of Korean PIMs list was produced. The second draft, including changes and their rationale, was submitted to the expert panel for approval. The final version of the Korean PIMs list was generated, with minor modifications of the second draft, to reflect the response to the fourth-round survey. Items for which no consensus was achieved in the fourth round were excluded from the final version.

Ethics Statement
----------------

The present study protocol was reviewed and approved by the Research Committee of Seoul Medical Center and the study was conducted in accordance with the principles of the Declaration of Helsinki.

RESULTS
=======

The final PIMs list is presented in [Tables 1](#t1-agmr-22-121){ref-type="table"} and [2](#t2-agmr-22-121){ref-type="table"}. The list targets older adults outside palliative care and includes medications that most older adults ([Table 1](#t1-agmr-22-121){ref-type="table"}) and older adults with specific conditions ([Table 2](#t2-agmr-22-121){ref-type="table"}) should avoid. The expert panel emphasizes that the medications in this list are not "absolutely contraindicated" but "potentially inappropriate"; thus, the medications can be used cautiously for older adults if clinicians judge that the potential benefit outweighs the risk.

PIMs for Older Adults ([Table 1](#t1-agmr-22-121){ref-type="table"})
--------------------------------------------------------------------

A total of 62 drugs were classified as PIMs for older adults irrespective of comorbidities, most of which were antipsychotics, tricyclic antidepressants (TCA), benzodiazepines, first-generation antihistamines, and nonsteroidal anti-inflammatory drugs (NSAID). Some antiparkinsonian drugs (benztropine, trihexyphenidyl), antispasmodics (clidinium-chlordiazepoxide, scopolamine), skeletal muscle relaxants (methocarbamol, orphenadrine), and oxybutynin were included in this list due to their strong anticholinergic properties. Among cardiovascular drugs, some antiarrhythmics (dronedarone, amiodarone, and flecainide), digoxin, and ticlopidine were included due to their worse clinical outcomes or higher risk of adverse events compared to those of available alternatives.

PIMs in Older Adults With Specific Conditions ([Table 2](#t2-agmr-22-121){ref-type="table"})
--------------------------------------------------------------------------------------------

A total of 48 drugs or drug categories were classified as PIMs for 18 specific conditions that older adults encounter frequently. The panel agreed that anticholinergics are especially inappropriate for older adults with cognitive problems, higher fall risk, constipation, lower urinary tract symptoms, or glaucoma, which includes first-generation antihistamines, bladder antimuscarinics, tricyclic antidepressants, and some antipsychotics. Benzodiazepine and zolpidem were also classified as PIMs for older patients with cognitive problems and higher fall risk. Antipsychotics and metoclopramide should be avoided in patients with Parkinson disease whenever possible. The panel agreed that NSAID use requires special precautions in older adults with heart failure, hypertension, chronic kidney disease, history of peptic ulcer, or concurrent bleeding disorders. The use of aspirin in older adults aged ≥80 years for cardiovascular primary prevention and the use of aspirin plus clopidogrel for stroke secondary prevention are discouraged except in special situations because they could increase bleeding risk without definite benefit. Hyponatremic older patients are recommended to avoid diuretics, some antidepressants and antipsychotics.

DISCUSSION
==========

We present a new PIMs list for Korean older adults that was developed in collaboration with major geriatric academic societies in Korea. The list was generated with the modified Delphi method referring to recently published international screening tools such as the 2015 Beers criteria and the revised STOPP.

A prospective, observational cohort study showed that the self-reported history of falls (odds ratio, 1.23; 95% confidence interval \[CI\], 1.04--1.45) and hospital admission (hazard ratio, 1.16; 95% CI, 1.08--1.24) were independently associated with the use of PIMs in community-dwelling older men.[@b14-agmr-22-121] Hamilton et al.[@b15-agmr-22-121] also showed in a European prospective study that the prescription of PIMs according to the original STOPP criteria was significantly associated with ADEs that cause or contribute to hospital admission in older adults. With the rapid increase of older populations, several studies regarding PIMs have been also published in Korea. Hwang et al.[@b16-agmr-22-121] reported that 58.2% of residents in long-term care facilities had received at least one PIM according to the 2012 Beers criteria and that the most prevalent PIMs were quetiapine, chlorpheniramine, risperidone, and zolpidem. A recent Korean retrospective study suggested that patients administered PIMs (defined using the 2012 Beers criteria) were more likely to be admitted to the hospital or visit emergency departments (ED).[@b17-agmr-22-121] In that study, the most commonly used PIMs were chlorpheniramine, diazepam, metoclopramide, and diclofenac. Although most Korean studies examining PIMs have used the Beers criteria, 38 of 111 drugs (34.2%) considered PIMs according to the 2015 Beers criteria are unavailable in Korea. Due to the absence of a Korean PIMs list, it is hard for physicians to apply a PIMs screening tool in their daily practice. The 2010 Kim's list has been the only published PIMs list for Korean older adults until now. However, it lacked a description of the applicable conditions or exceptions for each item and included some out-of-date items such as beta-blockers for heart failure and unavailable drugs such as tacrine, dipyridamole, and disopyramide.[@b9-agmr-22-121] Therefore, an updated list was required to incorporate recent advances in this field.

As there is no official geriatric training system in Korea, many Korean doctors might be unfamiliar with PIMs for older adults. For this reason, the expert panel agreed to provide a concise rather than exhaustive list, which can be easily adopted by doctors who treat older people, including primary care physicians and surgeons. To reduce the number of PIMs items, the research steering team excluded items with CSS \<9 points, with the possibility of re-entry in further Delphi rounds. We also merged some conditions sharing similar PIMs; for example, dementia with delirium, and history of falls with syncope and postural hypotension. Finally, we were able to produce a concise list including 62 general PIMs and 48 PIMs for 18 specific conditions compared to the 2015 Beers criteria, which included 113 general PIMs, 68 PIMs for 12 specific conditions, and 16 PIMs with caution. Despite the small number of items, the new list addresses common ADEs in the older population such as falls and cognitive problems,[@b18-agmr-22-121] and also includes most of the prevalent PIMs in Korea.[@b16-agmr-22-121],[@b17-agmr-22-121] To reflect the fact that gastrointestinal bleeding is a major ADE causing hospitalization or ED visit,[@b4-agmr-22-121],[@b5-agmr-22-121] the panel included aspirin in older adults aged ≥80 years for cardiovascular primary prevention and aspirin plus clopidogrel for secondary stroke prevention in the list. The panel also suggested less stringent glycated hemoglobin targets (\<7.5% or higher) for older patients with diabetes as a comment to reduce hypoglycemic events, which is another major cause of hospitalization related to ADEs.[@b19-agmr-22-121]

Some panelists were skeptical about the inclusion of antipsychotics in this list because nonpharmacological options such as behavioral intervention for Behavioral and Psychological Symptoms of Dementia management are rarely available in Korean hospitals and long-term care facilities. However, with increasing evidence of harm associated with antipsychotics[@b20-agmr-22-121] and conflicting evidence on their effectiveness,[@b21-agmr-22-121] the expert panel agreed that antipsychotics should be included in the list with the comments, "Short-term and low-dose antipsychotic (such as haloperidol, risperidone, and quetiapine) use might be appropriate for delirium or dementia if nonpharmacological options (e.g., behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others." Apart from this list, the multifaceted effort to reduce antipsychotics use especially in a long-term care setting is urgently required in Korea. There was substantial concern regarding the use of over-the-counter drugs containing first-generation antihistamines and herbal medicine in older adults, but the panel excluded these items from the final list because they could have too wide and vague range of application without concrete evidence. The panel did not reach a consensus regarding megestrol until the final round of survey and it was, thus, excluded.

This study has several limitations. Because of limited resources, we generated the preliminary list without evidence review for each item but rather from the review of existing criteria, which could result in the omission of recently introduced items. However, in view of the limited number of methodologically high-quality studies of older patients, the Delphi method based on existing criteria has been acknowledged as an acceptable way to generate a domestic PIMs list.[@b22-agmr-22-121],[@b23-agmr-22-121] Next, the relatively small number and low diversity of panel members was another limitation of the study; therefore, the additional participation of cardiologists, neurologists, and more primary care physicians and clinical pharmacists is required in future updates of the list. In addition, future updates could consider drug-drug interactions and PIMs based on kidney function that were not addressed in this study to make the lists concise. Finally, there could be several exceptional clinical situations in which the drugs on this list should be prescribed for older patients. The expert panel tried to address this issue in the Delphi rounds and described typical exceptional situations for each item in comments, but they are not enough to cover diverse clinical settings. Therefore, this PIMs list is only a reference to support better clinical decisions in the prescription for older patients and cannot substitute for clinical decision-making in specific medical situations.

Computerized decision support, where electronic alerts are produced to guide the prescriber, is an effective intervention in improving medication prescription in older adults.[@b24-agmr-22-121] In Korea, the nationwide drug utilization review (DUR) system was introduced in 2010 and the system is providing real-time safety alerts for prescribing long-acting benzodiazepines and TCA to older adults in outpatient clinics in Korea.[@b25-agmr-22-121] It would be valuable to incorporate selected drugs from this list in the DUR after proper validation.

We hope that this explicit PIMs list helps Korean physicians to make individualized therapeutic decisions for their older patients and improve medication safety. Further prospective studies to validate its usefulness in various clinical setting and regular updating of the list are required.
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###### 

Potentially inappropriate medications in older adults

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Organ system, drug category, drugs                 Rationale                                                                                                                                       Comments
  -------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Central nervous system                                                                                                                                                                             

                                                                                                                                                                                                     

   Antipsychotics                                    Increased mortality and stroke risk in dementia patients                                                                                        Exceptions: schizophrenia, bipolar disorder\
                                                                                                                                                                                                     Short-term and low-dose antipsychotic (such as haloperidol, risperidone, quetiapine) use might be appropriate for delirium or dementia if nonpharmacological options (e.g., behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others

   (1st generation)                                                                                                                                                                                  

    Chlorpromazine                                                                                                                                                                                   

   (2nd generation)                                                                                                                                                                                  

    Haloperidol                                                                                                                                                                                      

    Risperidone, Olanzapine, Clozapine, Quetiapine                                                                                                                                                   

                                                                                                                                                                                                     

   Antidepressants                                   Highly anticholinergic, sedating, and cause orthostatic hypotension                                                                             Possible alternatives: SSRIs, SNRIs or mirtazapine\
                                                                                                                                                                                                     Short-term and low-dose amitriptyline might be appropriate for neuropathic pain control

    Amitriptyline                                                                                                                                                                                    

    Amoxapine                                                                                                                                                                                        

    Clomipramine                                                                                                                                                                                     

    Doxepin (\>6 mg/day)                                                                                                                                                                             

    Nortriptyline                                                                                                                                                                                    

    Imipramine                                                                                                                                                                                       

                                                                                                                                                                                                     

   Benzodiazepines                                   High risk of dependence\                                                                                                                        Exceptions: seizure disorders, rapid eye movement sleep disorders, myoclonus, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia\
                                                     Increased risk of cognitive impairment, delirium, dizziness, falls, fractures, and motor vehicle crashes in older adults                        Try tapering if an older patient has been administered benzodiazepines\
                                                                                                                                                                                                     This drug list is not exhaustive, and other benzodiazepine drugs would be also inappropriate for older patients\
                                                                                                                                                                                                     If prescription is inevitable, prescribe short-acting agents such as alprazolam or lorazepam for a short duration

    (Short- and intermediate-acting)                                                                                                                                                                 

    Alprazolam                                                                                                                                                                                       

    Lorazepam                                                                                                                                                                                        

    Temazepam                                                                                                                                                                                        

    Triazolam                                                                                                                                                                                        

   (Long-acting)                                                                                                                                                                                     

    Chlordiazepoxide                                                                                                                                                                                 

    Clonazepam                                                                                                                                                                                       

    Diazepam                                                                                                                                                                                         

    Flurazepam                                                                                                                                                                                       

    Bromazepam                                                                                                                                                                                       

    Clobazam                                                                                                                                                                                         

    Flunitrazepam                                                                                                                                                                                    

                                                                                                                                                                                                     

   Zolpidem                                          Similar safety profile to benzodiazepines                                                                                                       If prescription is inevitable, prescribe medication for a short duration

                                                                                                                                                                                                     

   Antiparkinsonian agents                           Risk of anticholinergic side effects such as confusion, dry mouth, constipation, etc.                                                           Possible alternatives: levodopa for the treatment of Parkinson\'s disease

    Benztropine                                                                                                                                                                                      

    Trihexyphenidyl                                                                                                                                                                                  

                                                                                                                                                                                                     

   First-generation antihistamines                   Risk of anticholinergic side effects such as confusion, dry mouth, constipations, etc.                                                          Possible alternatives: second-generation antihistamines\
                                                                                                                                                                                                     This drug list is not exhaustive and other first-generation antihistamines are also inappropriate for older patients

    Chlorpheniramine                                                                                                                                                                                 

    Dimenhydrinate                                                                                                                                                                                   

    Diphenhydramine                                                                                                                                                                                  

    Hydroxyzine                                                                                                                                                                                      

    Triprolidine                                                                                                                                                                                     

                                                                                                                                                                                                     

  Cardiovascular system                                                                                                                                                                              

                                                                                                                                                                                                     

   Antiarrhythmics                                   Worse clinical outcomes or higher adverse events than those of other antiarrhythmics                                                            Rate control (with beta blockers or calcium channel blockers) is preferred over rhythm control in atrial fibrillation of older patients unless patients have heart failure or substantial left ventricular hypertrophy

    Dronedarone                                                                                                                                                                                      

    Amiodarone                                                                                                                                                                                       

    Flecainide                                                                                                                                                                                       

                                                                                                                                                                                                     

   Digoxin                                           May be associated with increased mortality in older adults with atrial fibrillation or heart failure                                            Avoid as a first-line therapy for atrial fibrillation or heart failure\
                                                                                                                                                                                                     Avoid dosages \>0.125 mg/day

                                                                                                                                                                                                     

   Ticlopidine                                       Altered blood counts and weak evidence                                                                                                          Possible alternatives: aspirin, clopidogrel

                                                                                                                                                                                                     

  Gastro-intestinal system                                                                                                                                                                           

                                                                                                                                                                                                     

   Metoclopramide                                    Extrapyramidal effects including tardive dyskinesia                                                                                             Short-term use might be appropriate

                                                                                                                                                                                                     

   Cimetidine                                        Can cause confusion and delirium                                                                                                                Possible alternatives: proton pump inhibitors(short-term)

                                                                                                                                                                                                     

   Antispasmodics                                    Risk of anticholinergic side effects such as confusion, dry mouth, constipation, etc.\                                                          
                                                     Uncertain effectiveness                                                                                                                         

    Clidinium-chlordiazepoxide                                                                                                                                                                       

    Scopolamine                                                                                                                                                                                      

                                                                                                                                                                                                     

  Kidney and urinary tract                                                                                                                                                                           

                                                                                                                                                                                                     

   Peripheral alpha-1 blockers                       High risk of orthostatic hypotension\                                                                                                           Not recommended as routine treatment for hypertension\
                                                     Alternative agents have superior risk-benefit profiles                                                                                          Possible alternatives for BPH treatment: tamsulosin, alfuzosin, naftopidil, silodosin

    Doxazosin                                                                                                                                                                                        

    Prazosin                                                                                                                                                                                         

    Terazosin                                                                                                                                                                                        

                                                                                                                                                                                                     

   Desmopressin                                      High risk of hyponatremia                                                                                                                       Exception: diabetes insipidus

                                                                                                                                                                                                     

    Oxybutynin                                       Risk of anticholinergic side effects such as confusion, dry mouth, constipation, etc.                                                           

                                                                                                                                                                                                     

  Endocrine system                                                                                                                                                                                   

                                                                                                                                                                                                     

   Estrogens±progestins                              Evidence of carcinogenic potential (breast and endometrium)\                                                                                    Especially contraindicated for patients with a history of breast cancer or venous thromboembolism
                                                     Lack of cardiovascular or cognitive protection                                                                                                  

                                                                                                                                                                                                     

   Growth hormone                                    Impact on body composition is small and associated with edema, arthralgia, carpal tunnel syndrome, gynecomastia, and impaired fasting glucose   Exception: hormone replacement after pituitary gland removal

                                                                                                                                                                                                     

   Insulin, sliding scale                            Higher risk of hypoglycemia without improvement in glucose control                                                                              Refers to the sole use of short- or rapid-acting insulins to manage or avoid hyperglycemia in the absence of basal or long-acting insulin\
                                                                                                                                                                                                     Less stringent HbA~1c~ targets (\<7.5% or higher) are appropriate for older patients with diabetes according to their comorbidities and functionalstatus

   Glibenclamide                                     Increased risk of hypoglycemia                                                                                                                  Possible alternatives: other oral hypoglycemic agents such as metformin

                                                                                                                                                                                                     

  Musculoskeletal system                                                                                                                                                                             

                                                                                                                                                                                                     

   Opioid analgesics                                 More commonly causes adverse CNS effects than other opioid analgesics                                                                           Possible alternatives: acetaminophen, oxycodone, buprenorphine patch

     Pethidine                                                                                                                                                                                       

     Pentazocine                                                                                                                                                                                     

                                                                                                                                                                                                     

   NSAIDs                                            Increased risk of GI bleeding, peptic ulcer disease and kidney injury\                                                                          This drug list is not exhaustive and other NSAIDs are also inappropriate for older patients\
                                                     Indomethacin is more likely to have adverse CNS effects than other NSAIDs                                                                       Can be used for a short duration (\<3 months) with proton-pump inhibitor or misoprostol but they do not completely eliminate GI bleeding risk\
                                                                                                                                                                                                     Possible alternatives: acetaminophen, COX-2 inhibitors

    Aspirin (\>325 mg/day)                                                                                                                                                                           

    Diclofenac                                                                                                                                                                                       

    Indomethacin                                                                                                                                                                                     

    Ibuprofen, Dexibuprofen                                                                                                                                                                          

    Ketorolac, includes parenteral                                                                                                                                                                   

    Mefenamic acid                                                                                                                                                                                   

    Naproxen                                                                                                                                                                                         

    Piroxicam                                                                                                                                                                                        

    Sulindac                                                                                                                                                                                         

                                                                                                                                                                                                     

   Skeletal muscle relaxants                         Poorly tolerated by older adults because of sedation and increased risk of fractures\                                                           
                                                     Uncertain effectiveness                                                                                                                         

    Methocarbamol                                                                                                                                                                                    

    Orphenadrine                                                                                                                                                                                     
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BPH, benign prostatic hyperplasia; CNS, central nervous system; COX, cyclooxygenase; GI, gastrointestinal; HbA~1c~, glycated hemoglobin; NSAID, nonsteroidal anti-inflammatory drug; SSRI, selective serotonin reuptake inhibitors; SNRI, serotonin-norepinephrine reuptake inhibitors.

###### 

Potentially inappropriate medications in older adults with specific conditions

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Organ system, disease, syndrome or condition                    Drug category, drugs                                                    Rationale                                                                            Comments
  --------------------------------------------------------------- ----------------------------------------------------------------------- ------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Central nervous system                                                                                                                                                                                                       

   Delirium, dementia or cognitive impairment                     Anticholinergics[\*](#tfn3-agmr-22-121){ref-type="table-fn"}\           Potential of inducing or deteriorating delirium, dementia and cognitive impairment   Short-term and low-dose antipsychotic use might be appropriate for delirium or dementia if non-pharmacological options (e.g., behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others
                                                                  Antipsychotics\                                                                                                                                              
                                                                  Benzodiazepines\                                                                                                                                             
                                                                  Zolpidem\                                                                                                                                                    
                                                                  H~2~-receptor antagonists\                                                                                                                                   
                                                                  Pethidine                                                                                                                                                    

   History of falls, fractures, syncope or postural hypotension   Anticholinergics[\*](#tfn3-agmr-22-121){ref-type="table-fn"}\           May cause ataxia, impaired psychomotor function, syncope, or additional falls        Exceptions for anticonvulsants: seizure, mood disorders Short-term opioid use with caution might be appropriate for moderate to severe pain management
                                                                  Anticonvulsants\                                                                                                                                             
                                                                  Antipsychotics\                                                                                                                                              
                                                                  Benzodiazepines\                                                                                                                                             
                                                                  Zolpidem\                                                                                                                                                    
                                                                  Opioids\                                                                                                                                                     
                                                                  Peripheral alpha-1 blockers                                                                                                                                  

   Insomnia                                                       Caffeine\                                                               CNS stimulant effects                                                                
                                                                  Methylphenidate\                                                                                                                                             
                                                                  Phenylephrine\                                                                                                                                               
                                                                  Pseudoephedrine\                                                                                                                                             
                                                                  Theophylline                                                                                                                                                 

   Parkinson disease                                              Antipsychotics Metoclopramide                                           Potential to worsen Parkinsonian symptoms                                            Exceptions: aripiprazole, quetiapine, clozapine (less likely to worsen Parkinson disease)

  Cardiovascular system                                                                                                                                                                                                        

   Heart failure                                                  Verapamil\                                                              Potential to worsen heart failure                                                    Verapamil and diltiazem can be used in mild heart failure with caution
                                                                  Diltiazem\                                                                                                                                                   
                                                                  NSAIDs\                                                                                                                                                      
                                                                  COX-2 inhibitors\                                                                                                                                            
                                                                  Pioglitazone\                                                                                                                                                
                                                                  TCAs                                                                                                                                                         

   Arrhythmia                                                     TCAs                                                                    Pro-arrhythmic effects                                                               

   Hypertension                                                   NSAIDs                                                                  Risk of exacerbation of hypertension                                                 Short-term use might be appropriate for mild hypertension (\<160/90 mmHg)\
                                                                                                                                                                                                                               Possible alternatives: acetaminophen

   Primary prevention in adults ≥80 years of age                  Aspirin                                                                 Lack of evidence of benefit versus risk in this age group                            Use with caution in adults ≥80 years of age

   Secondary stroke prevention                                    Aspirin plus clopidogrel                                                Lack of evidence of added benefit over clopidogrel monotherapy                       Exceptions: coronary stent(s) inserted in the previous 12 months, concurrent acute coronary syndrome, or high- grade symptomatic carotid arterial stenosis

  Gastro-intestinal system                                                                                                                                                                                                     

   History of gastric or duodenal ulcers                          Aspirin (\>325 mg/day)\                                                 Exacerbate existing ulcers or cause new ulcers                                       If other alternatives are not effective, gastroprotective agents (i.e., PPI or misoprostol) should be coprescribed
                                                                  Non-COX-2 selective NSAIDs                                                                                                                                   

   Chronic constipation                                           Anticholinergics[\*](#tfn3-agmr-22-121){ref-type="table-fn"}\           Exacerbate constipation                                                              Short-term (\<2 weeks) opioid use with laxatives might be appropriate for moderate to severe pain management
                                                                  Opioids                                                                                                                                                      

  Kidney and urinary tract                                                                                                                                                                                                     

   Chronic kidney disease (CrCl \<30 mL/min)                      NSAIDs\                                                                 Increased risk of acute kidney injury and further decline of renal function          Possible alternatives: acetaminophen, corticosteroids
                                                                  COX-2 inhibitors                                                                                                                                             

   Lower urinary tract symptoms, BPH                              Anticholinergics[\*](#tfn3-agmr-22-121){ref-type="table-fn"}            Decreased urinary flow and cause urinary retention                                   Exceptions: antimuscarinics for urinary incontinence

   SIADH or hyponatremia                                          Diuretics                                                               May exacerbate hyponatremia                                                          Antipsychotics, antidepressants[†](#tfn4-agmr-22-121){ref-type="table-fn"} and some other drugs[‡](#tfn5-agmr-22-121){ref-type="table-fn"} should also be used with caution

  Chronic obstructive pulmonary disease                           Theophylline as monotherapy                                             More effective agents (inhaler) are available                                        Theophylline is generally considered as a third-line bronchodilator after inhaled anticholinergics and beta- 2 agonists

  Concurrent bleeding disorder or high bleeding risk situation    Aspirin\                                                                Increased bleeding risk                                                              High bleeding risk includes uncontrolled severe hypertension, bleeding diathesis, or recent non- trivial spontaneous bleeding
                                                                  Clopidogrel\                                                                                                                                                 
                                                                  Ticlopidine\                                                                                                                                                 
                                                                  NSAIDs\                                                                                                                                                      
                                                                  Warfarin\                                                                                                                                                    
                                                                  Direct oral anticoagulants[§](#tfn6-agmr-22-121){ref-type="table-fn"}                                                                                        

  Diabetes                                                        Beta-blockers                                                           Masking of hypoglycemic symptoms                                                     Exceptions: heart failure, ischemic heart disease\
                                                                                                                                                                                                                               Avoid in diabetic patients with frequent hypoglycemic episodes (\>1 episode per month)

                                                                  Corticosteroids                                                         May worsen diabetes                                                                  Avoid long-term use

  Glaucoma                                                        Anticholinergics[\*](#tfn3-agmr-22-121){ref-type="table-fn"}            Risk of acute exacerbation of glaucoma                                               If other alternatives are not available, discuss with ophthalmologists
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BPH, benign prostatic hyperplasia; COX, cyclooxygenase; COPD, chronic obstructive pulmonary disease; CrCl, creatinine clearance; NSAID, nonsteroidal anti-inflammatory drug; PPI, proton-pump inhibitor; SIADH, syndrome of inappropriate antidiuretic hormone secretion; TCA, tricyclic antidepressant.

Anticholinergics include first-generation antihistamines, bladder antimuscarinics, antidepressants (tricyclic antidepressants and paroxetin), antipsychotics (chlorpromazine, clozapine, olanzapine, perphenazine), antispasmodics (belladonna alkaloid, clidinium-chlordiazepoxide, dicyclomine, scopolamine), antiparkinsonian agents (benztropine, trihexyphenidyl), skeletal muscle relaxants (cyclobenzaprine, orphenadrine), etc.

Antidepressants include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, mirtazapine, and bupropion.

Some other drugs include carbamazepine, oxcarbazepine, carboplatin, cyclophosphamide, cisplatin and vincristine.

Direct oral anticoagulants include dabigatran, rivaroxaban, apixaban, and edoxaban.
